Divergent Immune Responses to SARS-CoV-2 Vaccines in Immunocompromised Patients
Transplantation
.
2022 Jan 1;106(1):e90-e91.
doi: 10.1097/TP.0000000000003957.
Authors
Stanley C Jordan
1
,
Bong-Ha Shin
,
Terry-Ann M Gadsden
,
Maggie Chu
,
Anna Petrosyan
,
Ashley Vo
,
Noriko Ammerman
,
Supreet Sethi
,
Reiad Najjar
,
Ed Huang
,
Alice Peng
,
Mieko Toyoda
,
Sanjeev Kumar
,
Ruan Zhang
Affiliation
1
Division of Nephrology, Comprehensive Transplant Center, Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA.
PMID:
34582140
PMCID:
PMC8667672
DOI:
10.1097/TP.0000000000003957
Abstract
Supplemental Digital Content is available in the text.
MeSH terms
COVID-19 Vaccines* / immunology
COVID-19* / prevention & control
Humans
Immunity*
Immunocompromised Host*
Substances
COVID-19 Vaccines